Jennifer Sherr, MD, PhD
Yale University, Albuquerque, New Haven, Connecticut

Jennifer Sherr's passion for the care of those with type 1 diabetes (T1D) is quite personal, as she was diagnosed in 1987.  From the time of her diagnosis, she was determined to become a pediatric endocrinologist.  She completed her undergraduate and medical school training through an accelerated Joint BA/MD program at Rutgers University and the University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School.  She then completed both her pediatric residency and pediatric endocrinology fellowship at Yale.  While she always wanted to care for those with T1D, her eyes were open to the meaningful impact that clinical research has.  She thus embarked on further training through the Yale Graduate School of Arts and Sciences Investigative Medicine Program, a PhD program designed to develop the next generation of physician scientists.  Dr. Sherr has been devoted to clinical research over the past 9 years time.  Her thesis examined the mechanisms responsible for the loss of the glucagon response to hypoglycemia and its relationship to residual beta-cell function. She is also an active, and integral member of the artificial pancreas team at Yale.    Dr. Sherr has since focused her career on clinical strategies to improve closed loop insulin delivery, for which she has a JDRF Early Career Patient Oriented Diabetes Research Award.  Through this award she is exploring the application of adjunctive therapies in conjunction with closed loop insulin delivery to assess if they can mitigate post-prandial hyperglycemia. She has also worked on projects with the type 1 diabetes exchange (T1DX) and recently has been selected as the Junior Pediatric Faculty Member to the T1DX Steering Committee.  As an assistant professor in the department of pediatrics, her goal in both the clinical and research realm is to reduce the burden of living with type 1 diabetes, for both her patients and herself.